期刊论文详细信息
BMC Complementary and Alternative Medicine
Antinociceptive, muscle relaxant and sedative activities of gold nanoparticles generated by methanolic extract of Euphorbia milii
Mohammad Raza Shah1  Muhammad Shahid2  Naveed Muhammad3  Abdur Rauf4  Ibrahim Khan4  Nazar Ul Islam4 
[1]H.E.J. Research Institute of Chemistry, International Centre for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan
[2]Department of Pharmacy, Sarhad University of Science and Information Technology, Peshawar, Pakistan
[3]Department of Pharmacy, Abdul Wali Khan University, Mardan, Pakistan
[4]Institute of Chemical Sciences, University of Peshawar, Peshawar, Pakistan
关键词: Sedative;    Muscle relaxant;    Antinociceptive;    Herbal drugs;    Nanotechnology;    Euphorbia milii;    Gold nanoparticles;   
Others  :  1210265
DOI  :  10.1186/s12906-015-0691-7
 received in 2014-04-16, accepted in 2015-05-21,  发布年份 2015
PDF
【 摘 要 】

Background

Nanotechnology has potential future for enhancing therapeutic efficacy and reducing the unwanted effects of herbal drugs. The biological research on Euphorbia species has been supported by the use of some plants in traditional medicines. Many species of Euphorbia have been reported as having strong sedative and analgesic effects. In the present research work gold nanoparticles of Euphorbia milii methanolic extract (Au-EM) were synthesized, characterized and tested for antinociceptive, muscle relaxant and sedative activities.

Methods

Au-EM was prepared by stirring 1 mM warm trihydrated tetrachloroaurate solution with E. milii methanolic extract without using any external reducing agents. The gold nanoparticles were characterized by UV-Visible spectroscopy, infrared spectrophotometery, atomic force microscopy and scanning electron microscopy while their stability was evaluated against varying pH and different volumes of sodium chloride (NaCl). The metal sensing capacity of Au-EM was tested towards cobalt, copper, lead, mercury and nickel. Au-EM was evaluated in BALB/c mice at a dose of 10 and 20 mg/kg for antinociceptive, muscle relaxant and sedative activities in comparison with the crude E. milii methanolic extract.

Results

Au-EM showed remarkable stability in different NaCl and pH solutions. Au-EM produced significant (P < 0.01) antinociceptive effect at doses of 10 and 20 mg/kg as compared to the crude E. milii methanolic extract. In the rotarod test, Au-EM showed significant muscle relaxant effect at 10 mg/kg (P < 0.05) and 20 mg/kg (P < 0.01) after 30, 60 and 90 min. In an open field test significant sedative effect (P < 0.05) of Au-EM was observed at 10 and 20 mg/kg. Moreover significant detection sensitivity was demonstrated towards all the tested heavy metals.

Conclusions

These results concluded that the gold nanoparticles improved the potency of E. milii methanolic extract and exhibited significant analgesic, muscle relaxant and sedative properties. The significant metals sensing ability and enhanced stability in different NaCl and pH solutions may enable us to explore different formulations of E. milii gold nanoparticles for potentially effective and safe nano-herbal therapy.

【 授权许可】

   
2015 Islam et al.; licensee BioMed Central.

【 预 览 】
附件列表
Files Size Format View
20150605012608978.pdf 2026KB PDF download
Fig. 11. 13KB Image download
Fig. 10. 20KB Image download
Fig. 9. 11KB Image download
Fig. 8. 40KB Image download
Fig. 7. 23KB Image download
Fig. 6. 22KB Image download
Fig. 5. 19KB Image download
Fig. 4. 90KB Image download
Fig. 3. 62KB Image download
Fig. 2. 98KB Image download
Fig. 1. 28KB Image download
【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

Fig. 4.

Fig. 5.

Fig. 6.

Fig. 7.

Fig. 8.

Fig. 9.

Fig. 10.

Fig. 11.

【 参考文献 】
  • [1]Ansari S, Farha IM. Influence of nanotechnology on herbal drugs: A Review. J Adv Pharm Technol Res. 2012; 3(3):142-6.
  • [2]Csermely P, Agoston V, Pongor S. The efficiency of multi-target drugs: the network approach might help drug design. Trends Pharmacol Sci. 2005; 26(4):178-82.
  • [3]X-y T, Liu L. Drug discovery enters a new era with multi-target intervention strategy. Chin J Integr Med. 2012; 18:539-42.
  • [4]Bonifácio BV, da Silva PB. Nanotechnology-based drug delivery systems and herbal medicines: a review. Int J Nanomedicine. 2014; 9:1-15.
  • [5]Jiang W, Kim BY, Rutka JT, Chan WC. Advances and challenges of nanotechnology-based drug delivery systems. Expert Opin Drug Deliv. 2007; 4(6):621-33.
  • [6]Gunasekaran T, Haile T, Nigusse T, Dhanaraju MD. Nanotechnology: an effective tool for enhancing bioavailability and bioactivity of phytomedicine. Asian Pac J Trop Biomed. 2014; 4 Suppl 1:S1-S7.
  • [7]Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS Nano. 2009; 3(1):16-20.
  • [8]Mwine TJ, Van Damme P. Why do Euphorbiaceae tick as medicinal plants?: a review of Euphorbiaceae family and its medicinal features. J Med Plant Res. 2011; 5(5):652-62.
  • [9]Chaabi M, Freund-Michel V, Frossard N, Randriantsoa A, Andriantsitohaina R, Lobstein A. Anti-proliferative effect of Euphorbia stenoclada in human airway smooth muscle cells in culture. J Ethnopharmacol. 2007; 109(1):134-9.
  • [10]Mothana RA, Lindequist U, Gruenert R, Bednarski PJ. Studies of the in vitro anticancer, antimicrobial and antioxidant potentials of selected Yemeni medicinal plants from the island Soqotra. BMC Complement Altern Med. 2009; 9(1):7. BioMed Central Full Text
  • [11]Ravikanth V, Reddy VLN, Reddy AV, Ravinder K, Rao TP, Ram TS et al.. Three new ingol diterpenes from Euphorbia nivulia: evaluation of cytotoxic activity. Chem Pharm Bull (Tokyo). 2003; 51(4):431-4.
  • [12]Fatope MO, Zeng L, Ohayagha JE, McLaughlin JL. New 19-acetoxyingol diterpenes from the latex of Euphorbia poisonii (Euphorbiaceae). Bioorg Med Chem. 1996; 4(10):1679-83.
  • [13]Roe FJ, Peirce WE. Tumor promotion by Euphorbia latices. Cancer Res. 1961;21(3):338-44.
  • [14]Sudhakar M, Rao CV, Rao P, Raju DB, Venkateswarlu Y. Antimicrobial activity of Caesalpinia pulcherrima, Euphorbia hirta and Asystasia gangeticum. Fitoterapia. 2006; 77(5):378-80.
  • [15]Natarajan D, Britto SJ, Srinivasan K, Nagamurugan N, Mohanasundari C, Perumal G. Anti-bacterial activity of Euphorbia fusiformis-A rare medicinal herb. J Ethnopharmacol. 2005; 102(1):123-6.
  • [16]Atta AH, Mouneir SM. Evaluation of some medicinal plant extracts for antidiarrhoeal activity. Phytother Res. 2005; 19(6):481-5.
  • [17]Williams LA, Gossell‐Williams M, Sajabi A, Barton EN, Fleischhacker R. Angiotensin converting enzyme inhibiting and anti-dipsogenic activities of Euphorbia hirta extracts. Phytother Res. 1997; 11(5):401-2.
  • [18]Giovanelli A, Silva CLPAC, Medeiros L, Vasconcellos MC. The molluscicidal activity of the latex of Euphorbia splendens var. hislopii on Melanoides tuberculata (Thiaridae), a snail associated with habitats of Biomphalaria glabrata (Planorbidae). Mem Inst Oswaldo Cruz. 2001; 96(1):123-5.
  • [19]Zani CL, Marston A, Hamburger M, Hostettmann K. Molluscicidal milliamines from Euphorbia milii var. hislopii. Phytochemistry. 1993; 34(1):89-95.
  • [20]Ahmad VU, Hussain J, Hussain H, Jassbi AR, Ullah F, Lodhi MA et al.. First natural urease inhibitor from Euphorbia decipiens. Chem Pharm Bull (Tokyo). 2003; 51(6):719-23.
  • [21]Lanhers M-C, Fleurentin J, Dorfman P, Mortier F, Pelt J-M. Analgesic, antipyretic and anti-inflammatory properties of Euphorbia hirta. Planta Med. 1991; 57(03):225-31.
  • [22]Battu GR, Ethadi SR, Veda Priya G, Swathi Priya K, Chandrika K, Venkateswara Rao A et al.. Evaluation of antioxidant and anti-inflammatory activity of Euphorbia heyneana Spreng. Asian Pac J Trop Biomed. 2011; 1(2):S191-S4.
  • [23]Gaur K, Rana A, Nema R, Kori M, Sharma C. Anti-inflammatory and analgesic activity of hydro-alcoholic leaves extract of Euphorbia neriifolia Linn. Asian J Pharm Clin Res. 2009; 2(1):26-8.
  • [24]Ahmad VU, Hussain H, Bukhari IA, Hussain J, Jassbi AR, Dar A. Antinociceptive diterpene from Euphorbia decipiens. Fitoterapia. 2005; 76(2):230-2.
  • [25]Shi Q-W, Su X-H, Kiyota H. Chemical and pharmacological research of the plants in genus Euphorbia. Chem Rev. 2008; 108(10):4295-327.
  • [26]Ma Q-G, Liu W-Z, Wu X-Y, Zhou T-X, Qin G-W. Diterpenoids from Euphorbia fischeriana. Phytochemistry. 1997; 44(4):663-6.
  • [27]Appendino G, Szallasi A. Euphorbium: modern research on its active principle, resiniferatoxin, revives an ancient medicine. Life Sci. 1997; 60(10):681-96.
  • [28]Bani S, Suri K, Suri O, Sharma O. Analgesic and antipyretic properties of Euphorbia royleana latex. Phytother Res. 1997; 11(8):597-9.
  • [29]Vamsidhar I, Mohammed AH, Nataraj B, Rao CM, Ramesh M. Antinociceptive activity of Euphorbia heterophylla roots. Fitoterapia. 2000; 71(5):562-3.
  • [30]Rauf A, Muhammad N, Qaisar M, Uddin G, Hussain I. Preliminary Antinociceptive Studies of Methanol Extract of Euphorbia milli. Middle-East J Med Plants Res. 2012; 1(3):68-70.
  • [31]Manandhar NP, Sanjay M. Plants and people of Nepal. Portland, Oregon: Timber Press; 2002.
  • [32]Delgado I, De-Carvalho R, De-Oliveira A, Kuriyama S, Oliveira-Filho E, Souza C et al.. Absence of tumor promoting activity of Euphorbia milii latex on the mouse back skin. Toxicol Lett. 2003; 145(2):175-80.
  • [33]Freitas J, Presgrave O, Fingola F, Menezes M, Vasconcellos M, Schall V et al.. Toxicological study of the molluscicidal latex of Euphorbia splendens: irritant action on skin and eye. Mem Inst Oswaldo Cruz. 1991; 86:87-8.
  • [34]Pancorbo S, Hammer RH. Preliminary phytochemical investigation of Euphorbia millii. J Pharm Sci. 1972; 61(6):954-7.
  • [35]Muhammad N, Saeed M, Khan H. Antipyretic, analgesic and anti-inflammatory activity of Viola betonicifolia whole plant. BMC Complement Altern Med. 2012; 12(1):59-66. BioMed Central Full Text
  • [36]Muhammad N, Saeed M, Khan H, Haq I. Evaluation of n-hexane extract of Viola betonicifolia for its neuropharmacological properties. J Nat Med. 2013; 67(1):1-8.
  • [37]Goyal M, Nagori B, Sasmal D. Sedative and anticonvulsant effects of an alcoholic extract of Capparis decidua. J Nat Med. 2009; 63(4):375-9.
  • [38]Wagner V, Dullaart A, Bock A-K, Zweck A. The emerging nanomedicine landscape. Nat Biotechnol. 2006; 24(10):1211-8.
  • [39]Bogunia-Kubik K, Sugisaka M. From molecular biology to nanotechnology and nanomedicine. Biosystems. 2002; 65(2):123-38.
  • [40]Yadav D, Suri S, Choudhary A, Sikender M, Hemant BN. Novel approach: Herbal remedies and natural products in pharmaceutical science as nano drug delivery systems. Int J Pharm Tech. 2011; 3(3):3092-116.
  • [41]Khare CP. Indian herbal remedies: rational Western therapy, ayurvedic, and other traditional usage, Botany. Springer Science & Business Media; 2003.
  • [42]Sharma GD, Tripathi S. Experimental evaluation of dugdhika (Euphorbia prostrata w. Ait) for the treatment of ‘tamaka svasa’(bronchial asthma). Anc Sci Life. 1984; 3(3):143.
  • [43]Bakhshi GD, Langade DG, Desai VS. Prospective, Open Label Study of Euphorbia Prostrata Extract 100 mg in the Treatment of Bleeding Haemorrhoids. Bombay Hosp J. 2008; 50(4):577-83.
  • [44]Gupta P. The efficacy of Euphorbia prostrata in early grades of symptomatic hemorrhoids–a pilot study. Eur Rev Med Pharmacol Sci. 2011; 15(2):199-203.
  • [45]Cruz C, Kasper P, Cataldo A, Zamith H, Paumgartten F. Tumor promoter-like activity of the molluscicidal latex of 'Crown-of-Thorns' (Euphorbia milii var. hislopii) in the V79 metabolic cooperation assay. Braz J Med Biol Res. 1996; 29(11):1519-23.
  • [46]Vogg G, Mattes E, Rothenburger J, Hertkorn N, Achatz S, Sandermann H. Tumor promoting diterpenes from Euphorbia leuconeura L. Phytochemistry. 1999; 51(2):289-95.
  • [47]Norhanom A, Yadav M. Tumour promoter activity in Malaysian Euphorbiaceae. Br J Cancer. 1995; 71(4):776-9.
  • [48]Ghosh P, Han G, De M, Kim CK, Rotello VM. Gold nanoparticles in delivery applications. Adv Drug Deliv Rev. 2008; 60(11):1307-15.
  • [49]Lasagna-Reeves C, Gonzalez-Romero D, Barria M, Olmedo I, Clos A, Ramanujam VS et al.. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem Biophys Res Commun. 2010; 393(4):649-55.
  • [50]de Matos RA, Cordeiro TS, Samad RE, Vieira ND, Courrol LC. Green synthesis of stable silver nanoparticles using Euphorbia milii latex. Colloids Surf A Physicochem Eng Asp. 2011; 389(1):134-7.
  • [51]Valodkar M, Jadeja RN, Thounaojam MC, Devkar RV, Thakore S. Biocompatible synthesis of peptide capped copper nanoparticles and their biological effect on tumor cells. Mater Chem Phys. 2011; 128(1):83-9.
  • [52]Lin Z, Wu J, Xue R, Yang Y. Spectroscopic characterization of Au3+ biosorption by waste biomass of Saccharomyces cerevisiae. Spectrochim Acta A Mol Biomol Spectrosc. 2005; 61(4):761-5.
  • [53]Qaisar M, NaeemuddinGilani S, Farooq S. Preliminary Comparative Phytochemical Screening of Euphorbia Species. Amer-Eurasian J Agri & Environ Sci. 2012; 12(8):1056-60.
  • [54]Zhang Y, Chen Y, Westerhoff P, Crittenden J. Impact of natural organic matter and divalent cations on the stability of aqueous nanoparticles. Water Res. 2009; 43(17):4249-57.
  • [55]Gao W, Chan JM, Farokhzad OC. pH-responsive nanoparticles for drug delivery. Mol Pharm. 2010; 7(6):1913-20.
  • [56]Langer K, Balthasar S, Vogel V, Dinauer N, Von Briesen H, Schubert D. Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int J Pharm. 2003; 257(1):169-80.
  • [57]Auffan M, Rose J, Wiesner MR, Bottero J-Y. Chemical stability of metallic nanoparticles: a parameter controlling their potential cellular toxicity in vitro. Environ Pollut. 2009; 157(4):1127-33.
  • [58]Murphy CJ, Gole AM, Hunyadi SE, Stone JW, Sisco PN, Alkilany A et al.. Chemical sensing and imaging with metallic nanorods. Chem Commun. 2008; 5:544-57.
  • [59]Qu X, Alvarez PJ, Li Q. Applications of nanotechnology in water and wastewater treatment. Water Res. 2013; 47(12):3931-46.
  • [60]Järup L. Hazards of heavy metal contamination. Br Med Bull. 2003; 68(1):167-82.
  • [61]Garvey GJ, Hahn G, Lee RV, Harbison RD. Heavy metal hazards of Asian traditional remedies. Int J Environ Heal R. 2001; 11(1):63-71.
  • [62]Sahoo N, Manchikanti P, Dey S. Herbal drugs: standards and regulation. Fitoterapia. 2010; 81(6):462-71.
  • [63]Gerhardt A, Mcgraw NR, Schwartz DK, Bee JS, Carpenter JF, Randolph TW. Protein aggregation and particle formation in prefilled glass syringes. J Pharm Sci. 2014; 103(6):1601-12.
  • [64]Fradkin AH, Carpenter JF, Randolph TW. Glass particles as an adjuvant: a model for adverse immunogenicity of therapeutic proteins. J Pharm Sci. 2011; 100(11):4953-64.
  • [65]Matsumoto H, Naraba H, Ueno A, Fujiyoshi T, Murakami M, Kudo I et al.. Induction of cyclooxygenase-2 causes an enhancement of writhing response in mice. Eur J Pharmacol. 1998; 352(1):47-52.
  • [66]Dey P, Chandra S, Chatterjee P, Bhattacharya S. Neuropharmacological properties of Mikania scandens (L.) Willd.(Asteraceae). J Adv Pharm Technol Res. 2011; 2(4):255-9.
  • [67]Kaur R, Jaggi AS, Singh N. Studies on EŠect of Stress Preconditioning in Restrain Stress-induced Behavioral Alterations. Yakugaku Zasshi. 2010; 130(2):215-21.
  文献评价指标  
  下载次数:144次 浏览次数:65次